IDEXX Laboratories, Inc.  

(Public, NASDAQ:IDXX)   Watch this stock  
Find more results for Johnny Henderson�
-0.30 (-0.25%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 117.86 - 119.73
52 week 81.57 - 129.27
Open 118.42
Vol / Avg. 0.00/307,787.00
Mkt cap 6.09B
P/E 33.54
Div/yield     -
EPS 3.52
Shares 51.60M
Beta 0.78
Inst. own 101%
Apr 25, 2014
Q1 2014 Idexx Laboratories Earnings Release - 9:30AM EDT - Add to calendar
Apr 25, 2014
Q1 2014 Idexx Laboratories Earnings Conference Call - 8:30AM EDT - Add to calendar
Mar 4, 2014
Idexx Laboratories at Raymond James Financial Inc Institutional Investors Conference
Feb 4, 2014
Q4 2013 Idexx Laboratories Earnings Release
Feb 4, 2014
Q4 2013 Idexx Laboratories Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 12.21% 13.64%
Operating margin 17.32% 19.37%
EBITD margin - 23.34%
Return on average assets 14.30% 16.09%
Return on average equity 32.95% 32.54%
Employees 5,700 -
CDP Score - -


One IDEXX Drive
WESTBROOK, ME 04092-2041
United States - Map
+1-207-5560300 (Phone)
+1-207-5564346 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.

Officers and directors

Jonathan W. Ayers Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian P. McKeon Chief Financial Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
William E. Brown III, Ph.D. Executive Vice President, Chief Scientific Officer
Age: 58
Bio & Compensation  - Reuters
Jeffrey A. Fiarman Executive Vice President, General Counsel
Age: 44
Bio & Compensation  - Reuters
Jay Mazelsky Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Johnny D. Powers Ph.D. Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Michael J. Williams Ph.D. Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Daniel V. Meyaard Corporate Vice President - Worldwide Operations
Age: 55
Bio & Compensation  - Reuters
Giovani Twigge Corporate Vice President - Worldwide Human Resources
Age: 49
Bio & Compensation  - Reuters
Conan R. Deady Corporate Vice President, Secretary
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance